[HTML][HTML] Tumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell lymphoma

B Apollonio, F Spada, N Petrov… - The Journal of …, 2023 - Am Soc Clin Investig
Recent transcriptomic-based analysis of diffuse large B cell lymphoma (DLBCL) has
highlighted the clinical relevance of LN fibroblast and tumor-infiltrating lymphocyte (TIL) …

Tumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell lymphoma

B Apollonio, F Spada, N Petrov, D Cozzetto… - Journal of Clinical …, 2023 - diva-portal.org
Diffuse large B cell lymphoma (DLBCL) is an aggressive tumor of mature B cells that arises
in LNs (1). DLBCL remains incurable for approximately 40% of patients who experience …

[引用][C] Tumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell lymphoma

B Apollonio, F Spada, N Petrov, D Cozzetto… - Journal of Clinical …, 2023 - cir.nii.ac.jp
Tumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell
lymphoma | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …

Tumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell lymphoma

B Apollonio, CE Graham, D Cozzetto, R Benjamin… - 2023 - ikee.lib.auth.gr
Recent transcriptomic-based analysis of diffuse large B cell lymphoma (DLBCL) has
highlighted the clinical relevance of lymph node (LN) fibroblast and tumor-infiltrating …

Tumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell lymphoma.

B Apollonio, F Spada, N Petrov, D Cozzetto… - The Journal of …, 2023 - europepmc.org
Recent transcriptomic-based analysis of diffuse large B cell lymphoma (DLBCL) has
highlighted the clinical relevance of LN fibroblast and tumor-infiltrating lymphocyte (TIL) …

[PDF][PDF] Tumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell lymphoma

B Apollonio, F Spada, N Petrov, D Cozzetto… - 2023 - core.ac.uk
Diffuse large B cell lymphoma (DLBCL) is an aggressive tumor of mature B cells that arises
in LNs (1). DLBCL remains incurable for approximately 40% of patients who experience …

Tumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell lymphoma

B Apollonio, F Spada, N Petrov… - Journal of Clinical …, 2023 - search.proquest.com
Recent transcriptomic-based analysis of diffuse large B cell lymphoma (DLBCL) has
highlighted the clinical relevance of LN fibroblast and tumor-infiltrating lymphocyte (TIL) …

Tumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell lymphoma

B Apollonio, F Spada, N Petrov, D Cozzetto… - Journal of Clinical …, 2023 - eprints.gla.ac.uk
Recent transcriptomic-based analysis of diffuse large B cell lymphoma (DLBCL) has
highlighted the clinical relevance of LN fibroblast and tumor-infiltrating lymphocyte (TIL) …

Tumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell lymphoma

B Apollonio, F Spada, N Petrov… - The Journal of …, 2023 - pubmed.ncbi.nlm.nih.gov
Recent transcriptomic-based analysis of diffuse large B cell lymphoma (DLBCL) has
highlighted the clinical relevance of LN fibroblast and tumor-infiltrating lymphocyte (TIL) …

[PDF][PDF] Tumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell lymphoma

B Apollonio, F Spada, N Petrov, D Cozzetto… - 2023 - pdfs.semanticscholar.org
Diffuse large B cell lymphoma (DLBCL) is an aggressive tumor of mature B cells that arises
in LNs (1). DLBCL remains incurable for approximately 40% of patients who experience …